<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.3" -->
<rss version="2.0">
	<channel>
		<title>Death and Ironing Boards at the Washington Post</title>
		<description>Comments for Death and Ironing Boards at the Washington Post at http://www.cepr.net , comment 1 to 4 out of 4 comments</description>
		<link>http://www.cepr.net</link>
		<lastBuildDate>Thu, 23 May 2013 20:57:18 +0100</lastBuildDate>
        <generator>FeedCreator 1.7.3</generator>
		<item>
			<title>MAXIDEX      DEXAMETHASONE     WARNING</title>
			<link>http://www.cepr.net/index.php/blogs/beat-the-press/death-and-ironing-boards-at-the-washington-post#comment-2262</link>
			<description>I had eye surgery and in the post-op pack was   MAXIDEX(dexamethasone) drops by ALCON LABS.

Two days later I as    BLIND

Use Gogle and ente     EPOCRATES     MAXIDEX REACTION     to verify

Or call      800-757-9195


DEATH CONT is on ehealthme.com - WEL</description>
			<pubDate>Fri, 20 Aug 2010 01:22:06 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.cepr.net/index.php/blogs/beat-the-press/death-and-ironing-boards-at-the-washington-post#comment-1239</link>
			<description>Dean;
I hope you keep pounding on the message until someone in the media picks up on it, does a little investigation, and writes an expose.  Maybe someone from Rolling Stone, since they're becoming a publication to watch for investigative reporting.

The main deficit problem this country has going forward, even after we extricate ourselves from this current economic mess, will be the costs associated with our health care system, including pharmaceuticals.  Unless every cost attributable to health care is examined and reorganized to limit its size and scope, we will never again even approach a balanced budget and begin to pay down the debt.

I don't know how long it will be until this truth becomes common wisdom, but I thank you for doing what you can to educate those who will listen about the enormous giveaway to drug companies that is the obscene patent system for drug manufacturers. - Queen of Sheba</description>
			<pubDate>Wed, 30 Jun 2010 09:53:20 +0100</pubDate>
		</item>
		<item>
			<title>cure worse than the disease</title>
			<link>http://www.cepr.net/index.php/blogs/beat-the-press/death-and-ironing-boards-at-the-washington-post#comment-1224</link>
			<description>the other perverse money incentive is that drug companies make more for managing symptoms than curing- the irony is that a drug that cures diabetes would make less money for the industry than the umpteen diabetes drugs which help to manage symptoms (blood sugar, A1C, weight)- and, all drugs cause side effects, which if cardiac become quite serious- policy makers need to incentivize prevention, as the free market has evolved to me-too drugs which manage symptoms and are more expensive - frankenduf</description>
			<pubDate>Tue, 29 Jun 2010 03:28:44 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.cepr.net/index.php/blogs/beat-the-press/death-and-ironing-boards-at-the-washington-post#comment-1221</link>
			<description>From the WaPo article on ironing boards:

[quote]The company survives in part because it convinced U.S. trade officials that Chinese firms were unfairly dumping ironing boards into the United States at less than fair-market value; in response, the United States levied anti-dumping taxes of 70 to more than 150 percent on its Chinese rivals.[/quote]

So what's the problem?  This is exactly what Baker and Krugman have been recommending for China imports in general to correct the US trade deficit should it refuse to allow its currency to rise relative to the dollar, which is a form of dumping exports.

In reverse, Baker wants Big Pharma to &quot;dump&quot; its drugs at what, below fair market value, or is fair market value the dump price?  So the incentive to produce more dangerous drugs would be even higher since safety would be sacrificed for volume.

Stupid liberals. - izzatzo</description>
			<pubDate>Tue, 29 Jun 2010 00:33:30 +0100</pubDate>
		</item>
	</channel>
</rss>
